cstone pharmaceuticals
CStone Pharma Completes US$260 Million Series B Funding Round
The funds raised will primarily be used for clinical development of CS1001 and other clinical stage assets, as well as attract top industry talents.
China’s CStone Pharma Receives US$150 Million In Series A Financing
CStone Pharmaceuticals has closed a Series A round of financing with investments from Oriza Seed Venture Capital, Boyu Capital and WuXi Healthcare Ventures.
